Oncology Room

In this room you can find updates and expert discussions in oncology.

#VisualAbstract: Long-term pembrolizumab monotherapy maintains efficacy despite the occurrence of immune-related adverse events in patients with advanced melanoma

Quality Evidence Briefings Visual Abstracts

Quality Evidence Briefings, Cancer, Oncology, Skin cancer, Oncology Room

#VisualAbstract: Long-term pembrolizumab monotherapy maintains efficacy despite the occurrence of immune-related adverse events in patients with advanced melanoma

2 Minute Medicine

Jan 21, 2021

#VisualAbstract: Higher rate of hematologic second primary malignancies developed in multiple myeloma patients who received autologous hematopoietic stem cell transplants

Quality Evidence Briefings Visual Abstracts

Quality Evidence Briefings, Cancer, Haematological malignancies, Oncology Room

#VisualAbstract: Higher rate of hematologic second primary malignancies developed in multiple myeloma patients who received autologous hematopoietic stem cell transplants

2 Minute Medicine

Jan 21, 2021

Urgent cancer diagnostic services during COVID-19

Regulatory alerts

Regulatory Alerts, Cancer, Oncology, Oncology Room

Urgent cancer diagnostic services during COVID-19

Jan 19, 2021

NHS patients to benefit from first full access deal in Europe for new CAR-T therapy

Regulatory alerts NICE guidance

Regulatory Alerts, Cancer, Oncology, Haematological malignancies, Oncology Room

NHS patients to benefit from first full access deal in Europe for new CAR-T therapy

Jan 19, 2021

Regulatory alerts

Regulatory Alerts, Cancer, Oncology, Haematological malignancies, Thoracic cancer , Oncology Room

SMC accepts four oncology treatments

Treatments for multiple myeloma, lung cancer and lymphoma accepted for use within NHS Scotland.

Jan 18, 2021

HSJ exclusive: Give urgent cancer surgery the same priority as COVID patients, NHS England tells service

News, Cancer, Oncology, Oncology Room

HSJ exclusive: Give urgent cancer surgery the same priority as COVID patients, NHS England tells service

Jan 18, 2021

Quality Evidence Briefings Visual Abstracts

Quality Evidence Briefings, Oncology, Haematological malignancies, Oncology Room

#VisualAbstract AMLSG 09-09: Adding getuzumab ozogamicin (GO) to intensive therapy for Nucleophosmin1 mutated acute myeloid leukemia (NPM1mut AML) leads to better NPM1mut transcript clearance and a lower replase rate

2 Minute Medicine

Jan 15, 2021

Quality Evidence Briefings Visual Abstracts

Quality Evidence Briefings, Cancer, Oncology, Skin cancer, Oncology Room

#VisualAbstract: Durvalumab, trametinib, and dabrafenib triplet therapy may provide robust immunogenicity in patients with BRAF-mutated advanced melanoma

2 Minute Medicine

Jan 15, 2021

Niraparib recommended for maintenance treatment of advanced ovarian, fallopian tube and peritoneal cancer after response to first-line platinum-based chemotherapy

Regulatory alerts NICE guidance

Regulatory Alerts, Cancer, Oncology, Gynaecological cancer, Oncology Room

Niraparib recommended for maintenance treatment of advanced ovarian, fallopian tube and peritoneal cancer after response to first-line platinum-based chemotherapy

Jan 15, 2021

#VisualAbstract: Carboplatin as a potential adjunct therapy for recurrent high-grade glioma treatment

Quality Evidence Briefings Visual Abstracts

Quality Evidence Briefings, Neurology, Oncology Room

#VisualAbstract: Carboplatin as a potential adjunct therapy for recurrent high-grade glioma treatment

2 Minute Medicine

Jan 14, 2021

Accurate predictions of ovarian cancer outcome possible with new classification system, say researchers

News, Cancer, Oncology, Gynaecological cancer, Oncology Room

Accurate predictions of ovarian cancer outcome possible with new classification system, say researchers

Jan 14, 2021

#VisualAbstract: Everolimus plus leuprorelin and letrozole improves progression-free survival in HR⁺, HER2⁻ metastatic breast cancer patients with visceral metastases

Quality Evidence Briefings Visual Abstracts

Quality Evidence Briefings, Oncology, Breast cancer, Oncology Room

#VisualAbstract: Everolimus plus leuprorelin and letrozole improves progression-free survival in HR⁺, HER2⁻ metastatic breast cancer patients with visceral metastases

2 Minute Medicine

Jan 13, 2021

Statins may lower the risk of heart failure associated with anthracycline-based chemotherapy

Quality Evidence Briefings

Quality Evidence Briefings, Cardiology, Cardiovascular conditions, Oncology, Oncology Room

Statins may lower the risk of heart failure associated with anthracycline-based chemotherapy

2 Minute Medicine

Jan 12, 2021

Quality Evidence Briefings Visual Abstracts

Quality Evidence Briefings, Oncology, Haematological malignancies, Oncology Room

#VisualAbstract: Fondazione Italiana Linfomi (FIL) Phase 3 trial: Lenalidomide maintenance after autologous haematopoietic stem-cell transplantation (HSCT) in mantle cell lymphoma improves progression-free survival (PFS)

2 Minute Medicine

Jan 08, 2021

#VisualAbstract: Low-dose capecitabine after standard adjuvant therapy improves disease-free survival in patients with early triple-negative breast cancer

Quality Evidence Briefings Visual Abstracts

Quality Evidence Briefings, Cancer, Breast cancer, Oncology Room

#VisualAbstract: Low-dose capecitabine after standard adjuvant therapy improves disease-free survival in patients with early triple-negative breast cancer

2 Minute Medicine

Jan 08, 2021

Nivolumab not recommended for recurrent or metastatic head and neck cancer

Regulatory alerts NICE guidance

Regulatory Alerts, Cancer, Oncology, Head and neck cancer, Oncology Room

Nivolumab not recommended for recurrent or metastatic head and neck cancer

Jan 07, 2021

Encorafenib recommended as a treatment option for colorectal cancer

Regulatory alerts NICE guidance

Regulatory Alerts, Cancer, Gastrointestinal cancer, Oncology Room

Encorafenib recommended as a treatment option for colorectal cancer

Jan 06, 2021

Striking differences seen in COVID-19 responses in cancer patients

News, Cancer, Infections, Oncology, Oncology Room

Striking differences seen in COVID-19 responses in cancer patients

Jan 05, 2021

Study sheds light on genetic basis of Black men’s higher prostate cancer risk

News, Cancer, Oncology, Genitourinary cancers, Oncology Room

Study sheds light on genetic basis of Black men’s higher prostate cancer risk

Jan 04, 2021

#VisualAbstract: Presence of regression is a favourable prognostic factor for patients with stage I and II cutaneous melanoma

Quality Evidence Briefings Visual Abstracts

Quality Evidence Briefings, Cancer, Skin cancer, Oncology Room

#VisualAbstract: Presence of regression is a favourable prognostic factor for patients with stage I and II cutaneous melanoma

2 Minute Medicine

Jan 04, 2021

#VisualAbstract: Administering bortezomib on a weekly basis VS twice weekly basis does not significantly affect progression-free survival (PFS) or overall survival (OS) in Vrd first-line therapy for multiple myeloma

Quality Evidence Briefings Visual Abstracts

Quality Evidence Briefings, Haematological malignancies, Oncology Room

#VisualAbstract: Administering bortezomib on a weekly basis VS twice weekly basis does not significantly affect progression-free survival (PFS) or overall survival (OS) in Vrd first-line therapy for multiple myeloma

2 Minute Medicine

Jan 01, 2021